|  | 
                        
                        |  |  
                        |  |  
                        |  | 
	
	IQ 532® Laser System – Dual port green laser for comprehensive ophthalmology.MicroPulse® Laser Therapy for repeatable, tissue-sparing* glaucoma and retinal therapies. PRODUCT HIGHLIGHTS
    High power for greater range of therapy alternativesDual port for efficient setup of alternate delivery devicesRepeatable laser sessions for retinal diseases with optional MicroPulse module | 
	
	
Schedule a hands-on demoSchedule a no-obligation demo to see for yourself how MicroPulse Technology and Iridex’s Family of Products can take YOUR practice to the next level. |  
                        | 
                        
                        | 
	
 The Advantages of Innovation  High power for greater range of therapy alternativesHigh speed pulse durations for faster procedural timeDualSense provides quick and simple selection of multiple delivery devices for RFID and SMA Intelligent and intuitive design  Dual Port for efficient setup of alternate delivery devicesIntuitive graphic touch screen interface for ease of useProgrammable memory presets for multiple users  Optional Module for MicroPulse Laser Therapy, Fovea-Friendly* Repeatable laser sessions for retinal diseasesRepeatable glaucoma therapy with MicroPulse laser trabeculoplasty (MLT)  
    
        
        
            | Wavelength | 532 nm Green |  
            | Weight | 19.2 lb (9.0 kg) |  
            | Dimensions | 8.5" H x 12" W x 14" D (21 cm x 30 cm x 35 cm)
 |  
            | Connector Type 
 | RFID | Resistor |  
            | Electrical | 100-240 VAC, 50/60 Hz 
 |  
            | Cooling | Whisper fan |  
            | Exposure Duration | CW-Pulse: 10-3000 ms |  
            | Exposure Interval | CW-Pulse: 10-3000 ms |  
            | MicroPulse Duration | MicroPulse: 0.05-1.00 ms |  
            | MicroPulse Interval | MicroPulse: 1.00-10.00 ms |  
            | Aiming Laser | Diode laser, 635 nm nominal |  
            | Delivery Device Power Output | Portable SLA: 0-2000 mW LIO: 0-2000 mW
 EndoProbe: 0-2000 mW
 |   
    
        
            |  |  | IQ 532 Laser Product Video  |   
    
        
            |  |  | CombiningTissue-sparingMicroPulseTM LaserTherapyand Anti-VEGF Medication Produces Unprecedented Results in Radiation RetinopathyMicroPulse is a laser energy delivery modality that enables fine control of the thermal effects of photoco- agulation...  Download Now
 |  
            |  |  | MicroPulse™ Case Report - Diabetic Macular EdemaIridex has set the standard for probe technology, meeting surgical needs for small-gauge probes that consistently and accurately deliver laser treatment at a safe distance from the retina, without sacrificing illumination.  Download Now
 |  
            |  |  | 532 nm Subthreshold MicroPulse Effectively Reduces Diabetic Macular Edema after Failed Conventional Laser TreatmentIridex has set the standard for probe technology, meeting surgical needs for small-gauge probes that consistently and accurately deliver laser treatment at a safe distance from the retina, without sacrificing illumination.  Download Now
 |   Optional AccessoriesFull-Featured Remote Control  Compact design for easy placement or use in sterile field View displays and adjust parameters from two vantage points for increased convenience and efficiency Wireless Footswitch No cord, no clutter, no limitations Allows precise physician control over power settingsAvailable with power-adjust to control laser actuation and power settings      | Munir Escaf, MDRetina SpecialistClinica Carriazo Barranquilla
 Atlantico, Columbia
 |  |   | Jonathan Feistman, MDRetina SpecialistNYC Retina
 New York City, NY
 |  |   | Brian Horsman, MDDirector, Retina GroupBarnet Dulaney Perkins Eye Center
 Phoenix, AZ USA
 |  |   | Brandon Johnson, MDNYC RetinaNew York, NY USA
 |  |   | Ahad Mahootchi, MDMedical DirectorThe Eye Clinic of Florida
 Zephyrhills, FL
 |  |   | Walid Mangal, DOFlorida Vision InstituteStuart, FL USA
 |  |     | "By incorporating MicroPulse, my injection burden decreases by one-third at a minimum, which is a conservative estimate. The versatility of MicroPulse to treat retinal disorders and glaucoma allows me to provide my patients with a treatment that’s clinically effective, cost effective, and time effective.""MLT is both safe and durable. This therapy can be considered a first-line treatment for glaucoma patients, as well as patients who haven’t seen significant effects from medications." Jason Friedrichs, MD, MSFriedrichs Eye
 Sycamore, IL USA
 | "Compared to other lasers, the IQ 532 Laser with the MicroPulse module offers greater versatility because it can also be used for a range of other conditions including diabetic macular edema, proliferative diabetic retinopathy, and retinal tears. I'm comfortable offering MLT to glaucoma patients as a first-line option because of its potential to reduce intraocular pressure without causing tissue damage." David Gossage, DO, FAOCO, FAAOGossage Eye Institute
 Hillsdale, MI USA
 | "The MicroPulse P3 Device has become an essential part of my armamentarium for use in glaucoma surgical procedures. It provides a very safe and efficacious solution for IOP control. I have used MicroPulse P3 for some of my most complicated cases but also I feel comfortable enough using it for patients with earlier disease in which we want to avoid a filtering bleb or the placement of hardware in the eye." Robert Noecker, MD, MBAOphthalmic Consultants of Connecticut
 Fairfield, CT USA
 |   | "...treatment is less difficult and often takes less time than 532 nm." Dr. John T. HarriottWinston-Salem, NC
 |   | "The IQ532 Tx Cell Laser System is an invaluable adjunct in my armamentarium for a growing multitude of retinal and choroidal pathologies. In my hands, micropulse laser technology has achieved significant anatomic and functional gains as primary and combination therapy. The TxCell pattern delivery dramatically increases laser application efficiency, as well as patient comfort." Caesar Luo, MDBay Area Retina Associates
 Oakland, CA USA
 |   | "I have found the MicroPulse P3 Device to be a non-incisional, easy, and safe way to reduce pressure anytime my patients need it, and it is predictable and highly efficacious." Melissa Toyos, MDToyos Clinic
 Nashville, TN USA
 | "MLT is both safe and durable. This therapy can be considered a first-line treatment for glaucoma patients, as well as patients who haven’t seen significant effects from medications." Ike Ahmed, MD, FRCSCPrism Eye Institute
 Toronto, Ontario, Canada
 | "I have been impressed that the MicroPulse P3 therapy with the Cyclo G6 Glaucoma Laser can deliver pressure lowering in a broad range of glaucomas, including mild and moderate patients who I want to free from the adverse effects of drops." Rolando Toyos, MDToyos Clinic
 Nashville, TN USA
 |   | "The visualization of the ciliary body and the surrounding area is impressive. It has really helped me to deliver a patient-specific, targeted CPC treatment with an easy-to-use probe." Steven Vold, MDVold Vision
 Fayetteville, AR USA
 |   | "You can really consider TSCPC in almost all glaucoma situation, even malignant glaucoma. It is not just relegated to end-stage treatment anymore." Dr. Jeffrey KammerVanderbilt Eye Institute
 Nashville, TN
 | "TSCPC is a surgery that can be done before or after any other surgery. It is very versatile from that standpoint. " Nathan Radcliffe, MD
 New York Eye Surgery Center
 Bronx, NY USA
 | "Recovery with TSCPC is much more rapid and the postoperative care much less involved than with someone who has had an incisional glaucoma case in a surgical center." Steven Vold, MDVold Vision
 Fayetteville, AR USA
 |     | Lawrence Morse, MD, PhDUC DavisDavis, CA USA
 |  |   | Kishiko Ohkoshi, MDProfessor, Director, Chief Vitreoretinal SurgeonSt. Luke’s International University
 Tokyo, Japan
 |  |   | Julia Schulman, MD NYC Retina
 New York, NY USA
 |  |   | Stela Vujosevic, MD Professor, Medial Retina SpecialistUniversity Hospital Maggiore della Carita
 Novara, Italy
 |  |   | Glenn Yiu, MD, PhDUC DavisDavis, CA USA
 |  |   | Marco Zarbin, MD, PhD, FACSRutgers New Jersey Medical SchoolNewark, NJ USA
 |  |  MLT Focused   | "I achieved such good results with MLT that I decided to try MicroPulse for treating retinal diseases. I now use it daily to treat many retinal disorders, and MicroPulse allows me to treat patients who I could not have otherwise." Brandon Philips, MDCarolina Vision Center
 Fayetteville, NC USA
 | "MLT is versatile in variety of ways: for patients just starting therapy, replacing an eye drop, as an adjunct to an eye drop or to keep them away from incisional surgery." Nathan Radcliffe, MDNew York Eye Surgery Center
 Bronx, NY USA
 |   September 11, 2019: MicroPulse® Transscleral Laser Therapy Will be Discussed in Various Presentations and Educational Events at ESCRS 2019 in Paris, France June 3, 2019: Laser treatment for DME: Still a place at the table May 1, 2019: Study shows MicroPulse Laser controls IOP after Karatoplasty April 29, 2019: MicroPulse Laser featured in several Glaucoma and Retina research presentations at Ophthalmic Industry Conferences April 10, 2019: Meet MicroPulse TSCPC Experts at ASCRS in San Diego on May 4-6, 2019 April 8, 2019: ASCRS Breakfast: MicroPulse TSCPC as a Treatment for Failed MIGS Procedures April 1, 2019: The Role of Laser for Retinal Vascular Disease in the Anti-VEGF Era April 1, 2019: MicroPulse featured in multiple abstracts, posters, and presentations at WGC March 1, 2019: How does wavelength factor into choosing a laser? by Caesar Luo, MD January 14, 2019: Subthreshold Laser Treatment for Macular Edema by Matteo Forlini, MD June 25, 2018: Iridex Announces Multiple Studies of MicroPulse® Laser Therapy Published at World Ophthalmology Congress May 17, 2018: Iridex MicroPulse Technology Featured In Many Scientific Presentations at the European Glaucoma Society Meeting May 02, 2018: Iridex Announces Dramatic Increase In MicroPulse Visibility at the 2018 ARVO Meeting September 06, 2017: Iridex Explored on Innovations Breakthrough Series |  |  |  
                        | 
	
	
*Bhagat N, Zarbin M, Mansour S, Chong V, and Cardillo JA. Fovea-friendly MicroPulse Laser. Supplement to Retina Today, May/June 2012 |  |  |